ストックスクリーナーアプリを入手
9.21
1.32%
0.12
前日終値:
$9.09
開ける：
$9.15
24時間の取引高:
290.59K
Relative Volume:
2.52
時価総額：
$79.20M
収益：
$44.33M
当期純損益:
$16.05M
株価収益率:
28.17
EPS:
0.3269
ネットキャッシュフロー:
$3.85M
1週間 パフォーマンス:
-37.30%
1か月 パフォーマンス:
-45.37%
6か月 パフォーマンス:
-71.95%
1年 パフォーマンス:
-72.09%
1日の値動き範囲:
$8.75
$9.69
1週間の範囲:
$8.30
$15.40
52週間の値動き範囲:
$8.30
$46.59
Sanuwave Health Inc Stock (SNWV) Company Profile
Compare SNWV vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SNWV
Sanuwave Health Inc
|
29.00 | 34.02M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
2.38 | 3.16B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
6.54 | 425.01M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.26 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.909 | 269.09M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
46.61 | 0 | 0 | 0 | 0 | 0.00 |
Sanuwave Health Inc Stock (SNWV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-03 | 開始されました | Northland Capital | Outperform |
| 2025-07-29 | 開始されました | Roth Capital | Buy |
Sanuwave Health Inc (SNWV) 最新ニュース
SNWV: UltraMIST leverages clinical evidence and a consumables model to drive growth amid industry shifts - TradingView
Sanuwave Health eyes revenue up to USD 9.5M in Q2 2026 - Medical Buyer
Sanuwave Health expects Q2 revenue of $8.5M-$9.5M - scanx.trade
Sanuwave cuts Q2 revenue guidance on weak equipment sales By Investing.com - Investing.com South Africa
Sanuwave Health, Inc. Updates Earnings guidance for the Second Quarter 2026 - marketscreener.com
Sanuwave Health Cuts Q2 Revenue Guidance Amid Market Pressures - TipRanks
Sanuwave Health Updates Second Quarter 2026 Guidance - The Manila Times
Sanuwave updates Q2 revenue guidance to $8.5–$9.5M, applicator demand strong despite Ultramist headwinds - TradingView
Press Release: Sanuwave Health Updates Second Quarter 2026 Guidance - Moomoo
Sanuwave Health shareholders elect directors and approve auditor at annual meeting - Investing.com
Sanuwave Health Stockholders Approve Directors and Governance Matters - TipRanks
SANUWAVE Health (SNWV) Retreats From Resistance, Testing Key Support LevelsLast Point Support - newsline.com
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: Deep EPS Miss Raises Concerns Despite Stock RallyRevenue Warning Signal - newsline.com
SANUWAVE Health Q1 2026 Earnings: EPS Misses Estimates; Stock Rises Despite Wider LossROE Trend Analysis - newsline.com
SNWV: Director elections, auditor ratification, and executive pay were voted on; results pending - TradingView
SANUWAVE Health Inc Annual Shareholders Meeting Transcript - GuruFocus
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: Wider-than-Expected Loss Amid Pre-Commercialization PhaseConsensus Miss Rate - newsline.com
Sanuwave (SNWV) Q4 2025 Earnings Transcript - The Globe and Mail
SANUWAVE Reports Record Q4 Revenue and Surging System Sales - HarianBasis.co
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: EPS Falls Short of Estimates, Stock DeclinesAnalyst Consensus Shift - newsline.com
SANUWAVE Health (SNWV) Slips 1.14% as Stock Tests Support Near $15.65Cash Secured Put - newsline.com
SANUWAVE Health (SNWV) Shows Strength: Shares Gain Over 4% Amid Bullish Technical SetupMAMA Signal - The Legal Advocate
SNWV Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock DeclinesRevenue Guidance Update - newsline.com
SANUWAVE Health Inc. Q1 2026 Earnings: Significant EPS Miss Leads to Stock DeclineAI Trading Community - Newser
SANUWAVE Health Q1 2026 Earnings: EPS Misses Estimates by 283.8%, Revenue Not Disclosed - Newser
SANUWAVE Health (SNWV) Slips as Stock Tests Key Support Levels Near $16Ascending Triangle - thelegaladvocate.com
SANUWAVE Health Inc. (SNWV) Slips 1.82% as Stock Nears Key Support ZoneChange of Character - Newser
Shareholders Shouldn’t Be Too Comfortable With SANUWAVE Health's (NASDAQ:SNWV) Strong Earnings - Sahm
SANUWAVE Health (SNWV) Q1 2026 Results Miss Estimates — EPS $-0.18 vs $-0.05Debt/EBITDA - Newser
Number of shareholders of SANUWAVE Health, Inc. – NASDAQ:SNWV - TradingView
Sanuwave forecasts Q2 revenue of $11.1M-$11.6M while maintaining $51M-$55M full-year outlook - MSN
Is SANUWAVE Health (SNWV) 212.1% Overvalued After Q1 2026 EPS -$ - GuruFocus
Sanuwave Health Reports Record Q1 2026 Revenue of $9.6 Million - HarianBasis.co
SANUWAVE Health Reports Record Revenue for First Quarter 2026 - HarianBasis.co
SANUWAVE Health Inc (SNWV) Q1 2026 Earnings Call Highlights: Rec - GuruFocus
SANUWAVE Health Balances Growth, Margin Pressure in Q1 - TipRanks
Sanuwave (SNWV) Q1 2026 Earnings Transcript - AOL.com
Sanuwave Health Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: SANUWAVE Health sees Q1 revenue growth in 2026 - Investing.com Nigeria
SNWV: Record Q1 revenue and strong outlook signal recovery and growth momentum for 2026 - TradingView
SANUWAVE Health Inc Reports Q1 2026 Results: Full Earnings Call Transcript - Yahoo Finance
SANUWAVE Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
SANUWAVE Health, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SNWV) 2026-05-13 - Seeking Alpha
SANUWAVE Health, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
SNWV: Q1 2026 revenue up 3% year-over-year; FY 2026 revenue guidance raised to $51–$55M - TradingView
Sanuwave (SNWV) Reports Q1 Revenue Growth Amid Signs of Recovery - GuruFocus
Sanuwave Health Inc. (SNWV) reports Q1 loss, beats revenue estimates - MSN
Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates - sharewise.com
Sanuwave Health (SNWV) Projects Revenue Growth for FY26 - GuruFocus
Sanuwave Health Inc (SNWV) 財務データ
収益
当期純利益
現金流量
EPS
Sanuwave Health Inc (SNWV) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
May 01 '26 |
Sale |
16.11 |
10,581 |
170,465 |
5,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 28 '26 |
Sale |
18.47 |
46,288 |
854,819 |
7,500 |
| Opaleye Management Inc. | 10% Owner |
Apr 29 '26 |
Sale |
17.25 |
24,360 |
420,152 |
6,500 |
| Opaleye Management Inc. | 10% Owner |
Apr 17 '26 |
Sale |
20.46 |
16,267 |
332,841 |
10,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 21 '26 |
Sale |
20.50 |
202 |
4,142 |
954,798 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 11 '25 |
Sale |
31.28 |
13,500 |
422,277 |
70,499 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 12 '25 |
Sale |
21.04 |
6,500 |
136,789 |
63,999 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 08 '25 |
Sale |
30.75 |
125,400 |
3,856,050 |
881,390 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 09 '25 |
Sale |
30.58 |
8,785 |
268,679 |
872,605 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 10 '25 |
Sale |
30.39 |
8,625 |
262,129 |
863,980 |
0.93%
大文字化:
|
ボリューム (24 時間):